CRISPR Genomic Cure Market Synopsis:

CRISPR Genomic Cure Market Size Was Valued at USD 11.7 Billion in 2023, and is Projected to Reach USD 63.3 Billion by 2032, Growing at a CAGR of 20.6% From 2024-2032.

The CRISPR Genomic Cure industry refers to that part of biotechnology and life science that focuses on the use of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology for novel therapies and solutions to cure genetic diseases and precision medicine and other fields of healthcare, agriculture, and biotechnology. It involves tools, platforms, and therapeutic products utilized for the genome editing properties of CRISPR to make specific changes in DNA sequences in unprecedented accuracy to open up possibilities for revolutionary cures and significant improvements.

The CRISPR Genomic Cure industry is leading the way in the forefront of biotechnological innovation: revolutionary changes in the art of genome editing. It has essentially rearranged genetic research and the rationale for developing therapies, as it will be possible to make precise changes to DNA sequences. This trend to change applications with regard to healthcare, agriculture, and drug development restrains the market.

CRISPR is also at the front of gene therapy for diseases including sickle cell anemia, cystic fibrosis, and certain types of cancer. Apart from eradicating genetic disorders, it is of utmost importance for drugs insofar as development tools towards drug targets and diagnostic tools for diseases. In agriculture, the focus of CRISPR includes increases in crop yields, improvement towards resistance to diseases, and stress resilience in plants, indicating its role that transcends even healthcare alone.

Investments and partnerships among pharmaceutical companies, biotechnology firms, and research institutions are driving this market's growth. However, ethical issues, regulatory complexities, and technical challenges relating to off-target effects are major barriers. The market, however, is growing because of continued research, enhanced regulatory regimes in certain regions, and public-private collaborations.

CRISPR Genomic Cure Market Trend Analysis:

Increasing Adoption of CRISPR for Rare Genetic Diseases

  • The growing adoption of CRISPR for treating rare genetic diseases is a significant trend reshaping the genomic cure landscape. Rare diseases, often caused by specific genetic mutations, have historically lacked effective treatments. CRISPR’s ability to target and correct these mutations has positioned it as a transformative tool in rare disease therapy development.

  • The company now is willing to invest significant amounts to develop the CRISPR-related therapies with a concentration on every patient's specific genetic makeup, marking the entry point of precision medicine. More regulatory approvals may come about with advancement in research studies, which could open doors for patients throughout the world looking forward to more hope.

Expanding Applications in Agriculture

  • The agricultural sector now presents many opportunities with CRISPR, driving the application of this technology beyond that of medicine. Global challenges, such as climate change and food security, along with the need for sustainable farming, have driven the conception of CRISPR-based solutions to improve crop traits, nutritional value, and reduce reliance on chemical fertilizers and pesticides.

  • Drought-resistant crops-the application of CRISPR enables the crops to continue production for farmers under adverse environmental conditions. Pest-resistant plants and fortified crops with better nutritional profiles are some of the examples further showing how it can change the face of agriculture. Such applications benefit farmers and, consequently, food security for the rest of the world, thus making agriculture a very attractive growth vertical for the CRISPR Genomic Cure Market.

CRISPR Genomic Cure Market Segment Analysis:

CRISPR Genomic Cure Market Segmented on the basis of technology, delivery mode, application, end user and region.

By Technology, CRISPR/Cas9 segment is expected to dominate the market during the forecast period

  • By technology, the CRISPR/Cas9 segment is expected to dominate the market during the forecast period due to its proven effectiveness, precision, and broad applicability. As the most established genome-editing tool, CRISPR/Cas9 offers high efficiency and versatility in modifying genetic material, making it a preferred choice in various fields.

  • In gene therapy, it enables targeted correction of genetic disorders, while in agriculture, it is used to develop disease-resistant and high-yield crops. Additionally, its applications in biomedical research are expanding rapidly, particularly in the development of personalized medicine and drug discovery. The continued advancement of CRISPR/Cas9 technologies, coupled with increasing investments in genetic research, is expected to fuel the growth of this segment across industries.

By Application, Gene Therapy segment expected to held the largest share

  • Gene therapy represents the most prominent application where CRISPR is used to treat genetic disorders by repairing or replacing deficient genes. This segment is quickly growing because of an increase in genetic diseases and growing investment focused on precision medicine.

  • While these aspects revolutionize diagnostics with high specificity and speed, they also open agriculture research into pest-resistant and climate-resilient crops. That such a wide range of applications are technically feasible using CRISPR shows its potential to revolutionize many sectors.

CRISPR Genomic Cure Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

  • North America dominates the CRISPR Genomic Cure Market, driven by robust biotechnology and pharmaceutical industries, extensive research funding, and supportive regulatory frameworks. The region is home to numerous leading CRISPR-focused companies and academic institutions conducting pioneering research.

  • A major focus on precision medicine and rapid infusion of advanced technologies, North America's leadership is furthered through government initiatives complemented with private investments in genetic research, which further enhances the market, in turn establishing the region as a global center for CRISPR-based innovations.

Active Key Players in the CRISPR Genomic Cure Market:

  • CRISPR Therapeutics (Switzerland)
  • Editas Medicine (United States)
  • Intellia Therapeutics (United States)
  • Beam Therapeutics (United States)
  • Caribou Biosciences (United States)
  • Mammoth Biosciences (United States)
  • Synthego Corporation (United States)
  • Inscripta (United States)
  • Horizon Discovery Group (United Kingdom)
  • Cellectis (France)
  • ToolGen (South Korea)
  • GenScript (China)
  • Other Active Players

Key Industry Developments in the CRISPR Genomic Cure Market:

  • In October 2023, Regeneron Pharmaceuticals, Inc., a biotechnology company, and Intellia Therapeutics, Inc., a biotechnology company, announced an expanded research collaboration to develop additional in vivo CRISPR-based gene editing therapies focused on neurological and muscular diseases.

  • In June 2023, Parse Biosciences, a leading provider of accessible and scalable single-cell sequencing solutions, announced the launch of CRISPR Detect, enabling single-cell pooled CRISPR screens at unprecedented scale.

Global CRISPR Genomic Cure Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 11.7 Billion

Forecast Period 2024-32 CAGR:

 20.6%

Market Size in 2032:

USD 63.3 Billion

Segments Covered:

By Technology

  • CRISPR/Cas9
  • CRISPR/Cpf1
  • Base Editing
  • Prime Editing

By Application
  • Gene Therapy
  • Drug Development
  • Agriculture
  • Biomedical Research
  • Diagnostics

By Delivery Mode

  • Ex Vivo
  • In Vivo

By End User
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)
  • Hospitals and Clinics

By Region
  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:
  • Advancements in CRISPR Technology

Key Market Restraints:
  • Ethical and Regulatory Challenges

Key Opportunities:
  • Expanding Applications in Agriculture

Companies Covered in the report:
  • CRISPR Therapeutics (Switzerland), Editas Medicine (United States), Intellia Therapeutics (United States), Beam Therapeutics (United States), Caribou Biosciences (United States), and Other Active Players.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: CRISPR Genomic Cure Market by Application
 4.1 CRISPR Genomic Cure Market Snapshot and Growth Engine
 4.2 CRISPR Genomic Cure Market Overview
 4.3 Gene Therapy
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Gene Therapy: Geographic Segmentation Analysis
 4.4 Drug Development
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Drug Development: Geographic Segmentation Analysis
 4.5 Agriculture
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Agriculture: Geographic Segmentation Analysis
 4.6 Biomedical Research
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Biomedical Research: Geographic Segmentation Analysis
 4.7 Diagnostics
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 Diagnostics: Geographic Segmentation Analysis

Chapter 5: CRISPR Genomic Cure Market by End User
 5.1 CRISPR Genomic Cure Market Snapshot and Growth Engine
 5.2 CRISPR Genomic Cure Market Overview
 5.3 Biotechnology and Pharmaceutical Companies
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Biotechnology and Pharmaceutical Companies: Geographic Segmentation Analysis
 5.4 Academic and Research Institutes
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Academic and Research Institutes: Geographic Segmentation Analysis
 5.5 Contract Research Organizations (CROs)
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Contract Research Organizations (CROs): Geographic Segmentation Analysis
 5.6 Hospitals and Clinics
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Hospitals and Clinics: Geographic Segmentation Analysis

Chapter 6: CRISPR Genomic Cure Market by Technology
 6.1 CRISPR Genomic Cure Market Snapshot and Growth Engine
 6.2 CRISPR Genomic Cure Market Overview
 6.3 CRISPR/Cas9
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 CRISPR/Cas9: Geographic Segmentation Analysis
 6.4 CRISPR/Cpf1
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 CRISPR/Cpf1: Geographic Segmentation Analysis
 6.5 Base Editing
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Base Editing: Geographic Segmentation Analysis
 6.6 Prime Editing
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Prime Editing: Geographic Segmentation Analysis

Chapter 7: CRISPR Genomic Cure Market by Delivery Method
 7.1 CRISPR Genomic Cure Market Snapshot and Growth Engine
 7.2 CRISPR Genomic Cure Market Overview
 7.3 Ex Vivo
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Ex Vivo: Geographic Segmentation Analysis
 7.4 In Vivo
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 In Vivo: Geographic Segmentation Analysis

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Benchmarking
  8.1.2 CRISPR Genomic Cure Market Share by Manufacturer (2023)
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Mergers and Acquisitions  
 8.2 CRISPR THERAPEUTICS (SWITZERLAND)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Role of the Company in the Market
  8.2.5 Sustainability and Social Responsibility
  8.2.6 Operating Business Segments
  8.2.7 Product Portfolio
  8.2.8 Business Performance
  8.2.9 Key Strategic Moves and Recent Developments
  8.2.10 SWOT Analysis
 8.3 EDITAS MEDICINE (UNITED STATES)
 8.4 INTELLIA THERAPEUTICS (UNITED STATES)
 8.5 BEAM THERAPEUTICS (UNITED STATES)
 8.6 CARIBOU BIOSCIENCES (UNITED STATES)
 8.7 MAMMOTH BIOSCIENCES (UNITED STATES)
 8.8 SYNTHEGO CORPORATION (UNITED STATES)
 8.9 INSCRIPTA (UNITED STATES)
 8.10 HORIZON DISCOVERY GROUP (UNITED KINGDOM)
 8.11 CELLECTIS (FRANCE)
 8.12 TOOLGEN (SOUTH KOREA)
 8.13 GENSCRIPT (CHINA)
 8.14 OTHER ACTIVE PLAYERS

Chapter 9: Global CRISPR Genomic Cure Market By Region
 9.1 Overview
 9.2. North America CRISPR Genomic Cure Market
  9.2.1 Key Market Trends, Growth Factors and Opportunities
  9.2.2 Top Key Companies
  9.2.3 Historic and Forecasted Market Size by Segments
  9.2.4 Historic and Forecasted Market Size By Application
  9.2.4.1 Gene Therapy
  9.2.4.2 Drug Development
  9.2.4.3 Agriculture
  9.2.4.4 Biomedical Research
  9.2.4.5 Diagnostics
  9.2.5 Historic and Forecasted Market Size By End User
  9.2.5.1 Biotechnology and Pharmaceutical Companies
  9.2.5.2 Academic and Research Institutes
  9.2.5.3 Contract Research Organizations (CROs)
  9.2.5.4 Hospitals and Clinics
  9.2.6 Historic and Forecasted Market Size By Technology
  9.2.6.1 CRISPR/Cas9
  9.2.6.2 CRISPR/Cpf1
  9.2.6.3 Base Editing
  9.2.6.4 Prime Editing
  9.2.7 Historic and Forecasted Market Size By Delivery Method
  9.2.7.1 Ex Vivo
  9.2.7.2 In Vivo
  9.2.8 Historic and Forecast Market Size by Country
  9.2.8.1 US
  9.2.8.2 Canada
  9.2.8.3 Mexico
 9.3. Eastern Europe CRISPR Genomic Cure Market
  9.3.1 Key Market Trends, Growth Factors and Opportunities
  9.3.2 Top Key Companies
  9.3.3 Historic and Forecasted Market Size by Segments
  9.3.4 Historic and Forecasted Market Size By Application
  9.3.4.1 Gene Therapy
  9.3.4.2 Drug Development
  9.3.4.3 Agriculture
  9.3.4.4 Biomedical Research
  9.3.4.5 Diagnostics
  9.3.5 Historic and Forecasted Market Size By End User
  9.3.5.1 Biotechnology and Pharmaceutical Companies
  9.3.5.2 Academic and Research Institutes
  9.3.5.3 Contract Research Organizations (CROs)
  9.3.5.4 Hospitals and Clinics
  9.3.6 Historic and Forecasted Market Size By Technology
  9.3.6.1 CRISPR/Cas9
  9.3.6.2 CRISPR/Cpf1
  9.3.6.3 Base Editing
  9.3.6.4 Prime Editing
  9.3.7 Historic and Forecasted Market Size By Delivery Method
  9.3.7.1 Ex Vivo
  9.3.7.2 In Vivo
  9.3.8 Historic and Forecast Market Size by Country
  9.3.8.1 Russia
  9.3.8.2 Bulgaria
  9.3.8.3 The Czech Republic
  9.3.8.4 Hungary
  9.3.8.5 Poland
  9.3.8.6 Romania
  9.3.8.7 Rest of Eastern Europe
 9.4. Western Europe CRISPR Genomic Cure Market
  9.4.1 Key Market Trends, Growth Factors and Opportunities
  9.4.2 Top Key Companies
  9.4.3 Historic and Forecasted Market Size by Segments
  9.4.4 Historic and Forecasted Market Size By Application
  9.4.4.1 Gene Therapy
  9.4.4.2 Drug Development
  9.4.4.3 Agriculture
  9.4.4.4 Biomedical Research
  9.4.4.5 Diagnostics
  9.4.5 Historic and Forecasted Market Size By End User
  9.4.5.1 Biotechnology and Pharmaceutical Companies
  9.4.5.2 Academic and Research Institutes
  9.4.5.3 Contract Research Organizations (CROs)
  9.4.5.4 Hospitals and Clinics
  9.4.6 Historic and Forecasted Market Size By Technology
  9.4.6.1 CRISPR/Cas9
  9.4.6.2 CRISPR/Cpf1
  9.4.6.3 Base Editing
  9.4.6.4 Prime Editing
  9.4.7 Historic and Forecasted Market Size By Delivery Method
  9.4.7.1 Ex Vivo
  9.4.7.2 In Vivo
  9.4.8 Historic and Forecast Market Size by Country
  9.4.8.1 Germany
  9.4.8.2 UK
  9.4.8.3 France
  9.4.8.4 The Netherlands
  9.4.8.5 Italy
  9.4.8.6 Spain
  9.4.8.7 Rest of Western Europe
 9.5. Asia Pacific CRISPR Genomic Cure Market
  9.5.1 Key Market Trends, Growth Factors and Opportunities
  9.5.2 Top Key Companies
  9.5.3 Historic and Forecasted Market Size by Segments
  9.5.4 Historic and Forecasted Market Size By Application
  9.5.4.1 Gene Therapy
  9.5.4.2 Drug Development
  9.5.4.3 Agriculture
  9.5.4.4 Biomedical Research
  9.5.4.5 Diagnostics
  9.5.5 Historic and Forecasted Market Size By End User
  9.5.5.1 Biotechnology and Pharmaceutical Companies
  9.5.5.2 Academic and Research Institutes
  9.5.5.3 Contract Research Organizations (CROs)
  9.5.5.4 Hospitals and Clinics
  9.5.6 Historic and Forecasted Market Size By Technology
  9.5.6.1 CRISPR/Cas9
  9.5.6.2 CRISPR/Cpf1
  9.5.6.3 Base Editing
  9.5.6.4 Prime Editing
  9.5.7 Historic and Forecasted Market Size By Delivery Method
  9.5.7.1 Ex Vivo
  9.5.7.2 In Vivo
  9.5.8 Historic and Forecast Market Size by Country
  9.5.8.1 China
  9.5.8.2 India
  9.5.8.3 Japan
  9.5.8.4 South Korea
  9.5.8.5 Malaysia
  9.5.8.6 Thailand
  9.5.8.7 Vietnam
  9.5.8.8 The Philippines
  9.5.8.9 Australia
  9.5.8.10 New Zealand
  9.5.8.11 Rest of APAC
 9.6. Middle East & Africa CRISPR Genomic Cure Market
  9.6.1 Key Market Trends, Growth Factors and Opportunities
  9.6.2 Top Key Companies
  9.6.3 Historic and Forecasted Market Size by Segments
  9.6.4 Historic and Forecasted Market Size By Application
  9.6.4.1 Gene Therapy
  9.6.4.2 Drug Development
  9.6.4.3 Agriculture
  9.6.4.4 Biomedical Research
  9.6.4.5 Diagnostics
  9.6.5 Historic and Forecasted Market Size By End User
  9.6.5.1 Biotechnology and Pharmaceutical Companies
  9.6.5.2 Academic and Research Institutes
  9.6.5.3 Contract Research Organizations (CROs)
  9.6.5.4 Hospitals and Clinics
  9.6.6 Historic and Forecasted Market Size By Technology
  9.6.6.1 CRISPR/Cas9
  9.6.6.2 CRISPR/Cpf1
  9.6.6.3 Base Editing
  9.6.6.4 Prime Editing
  9.6.7 Historic and Forecasted Market Size By Delivery Method
  9.6.7.1 Ex Vivo
  9.6.7.2 In Vivo
  9.6.8 Historic and Forecast Market Size by Country
  9.6.8.1 Turkiye
  9.6.8.2 Bahrain
  9.6.8.3 Kuwait
  9.6.8.4 Saudi Arabia
  9.6.8.5 Qatar
  9.6.8.6 UAE
  9.6.8.7 Israel
  9.6.8.8 South Africa
 9.7. South America CRISPR Genomic Cure Market
  9.7.1 Key Market Trends, Growth Factors and Opportunities
  9.7.2 Top Key Companies
  9.7.3 Historic and Forecasted Market Size by Segments
  9.7.4 Historic and Forecasted Market Size By Application
  9.7.4.1 Gene Therapy
  9.7.4.2 Drug Development
  9.7.4.3 Agriculture
  9.7.4.4 Biomedical Research
  9.7.4.5 Diagnostics
  9.7.5 Historic and Forecasted Market Size By End User
  9.7.5.1 Biotechnology and Pharmaceutical Companies
  9.7.5.2 Academic and Research Institutes
  9.7.5.3 Contract Research Organizations (CROs)
  9.7.5.4 Hospitals and Clinics
  9.7.6 Historic and Forecasted Market Size By Technology
  9.7.6.1 CRISPR/Cas9
  9.7.6.2 CRISPR/Cpf1
  9.7.6.3 Base Editing
  9.7.6.4 Prime Editing
  9.7.7 Historic and Forecasted Market Size By Delivery Method
  9.7.7.1 Ex Vivo
  9.7.7.2 In Vivo
  9.7.8 Historic and Forecast Market Size by Country
  9.7.8.1 Brazil
  9.7.8.2 Argentina
  9.7.8.3 Rest of SA

Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies

Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
 

Global CRISPR Genomic Cure Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 11.7 Billion

Forecast Period 2024-32 CAGR:

 20.6%

Market Size in 2032:

USD 63.3 Billion

Segments Covered:

By Technology

  • CRISPR/Cas9
  • CRISPR/Cpf1
  • Base Editing
  • Prime Editing

By Application
  • Gene Therapy
  • Drug Development
  • Agriculture
  • Biomedical Research
  • Diagnostics

By Delivery Mode

  • Ex Vivo
  • In Vivo

By End User
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)
  • Hospitals and Clinics

By Region
  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:
  • Advancements in CRISPR Technology

Key Market Restraints:
  • Ethical and Regulatory Challenges

Key Opportunities:
  • Expanding Applications in Agriculture

Companies Covered in the report:
  • CRISPR Therapeutics (Switzerland), Editas Medicine (United States), Intellia Therapeutics (United States), Beam Therapeutics (United States), Caribou Biosciences (United States), and Other Active Players.

Frequently Asked Questions :

What would be the forecast period in the CRISPR Genomic Cure Market research report?
The forecast period in the CRISPR Genomic Cure Market research report is 2024-2032.
Who are the key players in the CRISPR Genomic Cure Market?
CRISPR Therapeutics (Switzerland), Editas Medicine (United States), Intellia Therapeutics (United States), Beam Therapeutics (United States), Caribou Biosciences (United States), Mammoth Biosciences (United States), Synthego Corporation (United States), and Other Active Players.
What are the segments of the CRISPR Genomic Cure Market?
The CRISPR Genomic Cure Market is segmented into Technology, Delivery Mode, Application, End User and region. By Application, the market is categorized into Gene Therapy, Drug Development, Agriculture, Biomedical Research, Diagnostics. By End User, the market is categorized into Biotechnology and Pharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Hospitals and Clinics. By Technology, the market is categorized into CRISPR/Cas9, CRISPR/Cpf1, Base Editing, Prime Editing. By Delivery Method, the market is categorized into Ex Vivo, In Vivo. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Russia; Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
What is the CRISPR Genomic Cure Market?
The CRISPR Genomic Cure Market refers to that part of biotechnology and life science that focuses on the use of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology for novel therapies and solutions to cure genetic diseases and precision medicine and other fields of healthcare, agriculture, and biotechnology. It involves tools, platforms, and therapeutic products utilized for the genome editing properties of CRISPR to make specific changes in DNA sequences in unprecedented accuracy to open up possibilities for revolutionary cures and significant improvements.
How big is the CRISPR Genomic Cure Market?
CRISPR Genomic Cure Market Size Was Valued at USD 11.7 Billion in 2023, and is Projected to Reach USD 63.3 Billion by 2032, Growing at a CAGR of 20.6% From 2024-2032.